NDC 70602-004-01 - Exoden Cure Powder
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70602-004
- Requested NDC
- 70602-004-01
- Package NDCs from labels
- 70602-004-01, 70602-004-02, 70602-004-03, 70602-004-04, 70602-004-05, 70602-004-06
- Manufacturer
- LIFEON Corp. | Korea Shidenta
- Effective date
- 2022-03-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Exoden Cure Powder - LIFEON Corp. | Korea Shidenta | LIFEON Corp. | Korea Shidenta | 2022-03-09 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70602-004-02 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8f1a-d83d-e063-dadaa90ab31f | 70602-004_Exoden Cure Powder |
| 70602-004-04 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8f1a-d83d-e063-dadaa90ab31f | 70602-004_Exoden Cure Powder |
| 70602-004-06 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8f1a-d83d-e063-dadaa90ab31f | 70602-004_Exoden Cure Powder |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70602-004-01 | Exoden Cure Powder | 10 g in 1 POUCH | POWDER | 10 | 2 | |
| 70602-004-02 | Exoden Cure Powder | 1 in 1 CARTON | POWDER | 1 | 2 | |
| 70602-004-03 | Exoden Cure Powder | 30 g in 1 CONTAINER | POWDER | 30 | 2 | |
| 70602-004-04 | Exoden Cure Powder | 1 in 1 CARTON | POWDER | 1 | 2 | |
| 70602-004-05 | Exoden Cure Powder | 70 g in 1 CONTAINER | POWDER | 70 | 2 | |
| 70602-004-06 | Exoden Cure Powder | 1 in 1 CARTON | POWDER | 1 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BSS | BALANCED SALT SOLUTION | Alcon Laboratories, Inc. | 28488c7b-cf6a-4a03-916f-cc66b3afdc57 | 2023-12-14 | Warnings, Adverse reactions | 451W47IQ8X |
| Altachlore Sodium Chloride Hypertonicity | SODIUM CHLORIDE | Altaire Pharmaceuticals Inc. | dc0d94d8-4475-4956-8ded-bdb9496074e4 | 2023-12-09 | Warnings | 451W47IQ8X |
| TACT | DIPHENHYDRAMINE HYDROCHLORIDE, MENTHOL | Sato Pharmaceutical Inc., Ltd. | b6e2ee24-69de-4dfd-9081-b9537b7a7bad | 2023-12-04 | Warnings | BZ1R15MTK7 |
| Tact Cool Jelly | DIPHENHYDRAMINE HYDROCHLORIDE, LEVOMENTHOL | Sato Pharmaceutical Co., Ltd. | f34872c9-91b9-49db-8e41-5b54a069284a | 2023-12-01 | Warnings | BZ1R15MTK7 |
| Satohap | METHYL SALICYLATE, DL-CAMPHOR, L-MENTHOL | Sato Pharmaceutical Co., Ltd. | 348fde05-2797-4410-a1b2-99e64187c4fe | 2023-12-01 | Warnings | BZ1R15MTK7 |
| terrasil Eczema and Psoriasis Severe Outbreak | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | 4d7128fb-57f1-4d0d-a83a-daef40928ecd | 2023-11-30 | Warnings | 451W47IQ8X |
| terragen HG Formula Maximum Strength | GRAPHITE, SODIUM CHLORIDE, SYMPHYTUM OFFICINALE WHOLE, THUJA OCCIDENTALIS LEAFY TWIG | Aidance Scientific, Inc, DBA Aidance Skincare & Topical Solutions | e632c831-e25d-4d04-ba72-2327d25713b1 | 2023-11-30 | Warnings | 451W47IQ8X |
| Femstat C | ECHINACEA (ANGUSTIFOLIA), FUCUS VESICULOSUS, HYDRASTIS CANADENSIS, PHYTOLACCA DECANDRA, KREOSOTUM, NATRUM MURIATICUM, CANDIDA ALBICANS, LYCOPODIUM CLAVATUM, PULSATILLA (PRATENSIS), SEPIA | Energique, Inc. | 420119ca-f2bf-40e3-9e40-00498724c228 | 2023-11-30 | Warnings | 451W47IQ8X |
| Satohap | METHYL SALICYLATE, DL-CAMPHOR, L-MENTHOL | Sato Pharmaceutical Co., Ltd. | 3a2fc8ae-f1ac-4c64-8e75-d5fdb141aecf | 2023-11-28 | Warnings | BZ1R15MTK7 |
| Endopar | GLANDULA SUPRARENALIS SUIS, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, OOPHORINUM (SUIS), ORCHITINUM (BOVINE), PINEAL GLAND, THYROIDINUM, ARSENICUM ALBUM, BARYTA CARBONICA, NATRUM MURIATICUM, PHOSPHORICUM ACIDUM, PULSATILLA (PRATENSIS) | Energique, Inc. | 06375c3e-cc05-4450-9117-1d3dc72636eb | 2023-11-21 | Warnings | 451W47IQ8X |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8646d7ea-cf5e-607d-e053-2a91aa0aeca1 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86466121-7217-d053-e053-2a91aa0a8f8a | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 864669c9-5bdc-232f-e053-2a91aa0a1fc6 | 2023-11-14 | 451W47IQ8X | |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 86462e06-d221-36b7-e053-2991aa0a1d82 | 2023-11-14 | 451W47IQ8X | |
| Satohap Cool Type | CAMPHOR, MENTHOL, METHYL SALICYLATE | Sato Pharmaceutical Co., Ltd. | fe07a00a-2699-44d3-887d-bd068948ad7b | 2023-11-07 | Warnings | BZ1R15MTK7 |
| Mineffect nasal mist | CALCAREA SILICATA, SILICEA, SULPHUR, NATRUM MURIATICUM, FERRUM METALLICUM, FERRUM PHOSPHORICUM, PHOSPHORUS, FERRUM MURIATICUM, TITANIUM METALLICUM, | Kadesh Incoporation Co,Ltd | 3a29bf95-a8a3-4517-aedf-0cd4a91b349c | 2023-10-31 | Warnings | 451W47IQ8X |
| Insomnia | AQUILEGIA VULGARIS, AVENA SATIVA, CHAMOMILLA, COFFEA CRUDA, CYPRIPEDIUM PUBESCENS, HUMULUS LUPULUS, HYPERICUM PERFORATUM, KALI PHOSPHORICUM, MELATONIN, MELISSA OFFICINALIS, NATRUM MURIATICUM, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS | Liddell Laboratories, Inc. | 18c15f17-1a16-4595-9d23-20353363cd72 | 2023-10-31 | Warnings | 451W47IQ8X |
| Saline | NASAL | GERI-CARE PHARMACEUTICAL CORP | d293cc13-4043-0d58-e053-2995a90a3fbc | 2023-10-24 | Warnings | 451W47IQ8X |
| Natrum muriaticum | SODIUM CHLORIDE | Boiron | 8644ffef-f0ec-5c06-e053-2a91aa0ae83d | 2023-10-23 | 451W47IQ8X | |
| Aqua marina | SODIUM CHLORIDE | Boiron | 6a212a52-32be-21b8-e053-2991aa0aea2f | 2023-10-22 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.